Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1995-4-20
|
pubmed:abstractText |
Lovastatin was used to study the role of isoprenylated proteins on stimulus-induced increase of cytosolic Ca2+ in retinoic acid-differentiated U937 and HL-60 cells. Preincubation of the cells with lovastatin for 11-24 h reduced the Ca(2+)-influx induced by PAF of FMLP. The maximal decrease was 60% in U937 cells and 40% in HL-60 cells. The ID50s of lovastatin in U937 and HL-60 cells were 5 microM and 15 microM, respectively. Lovastatin did not inhibit Ca(2+)-discharge from intracellular stores. Addition of mevalonate to lovastatin-treated cells completely reversed the inhibition of PAF- and FMLP-stimulated Ca(2+)-mobilization. Immunoreactivity of ras-like proteins was decreased in membranes and increased in the cytosol of U937 cells by 1 day treatment with lovastatin. We conclude that isoprenylated proteins are involved in the regulation of receptor-stimulated Ca(2+)-entry of differentiated HL-60 and U937 cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0898-6568
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
735-42
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7888300-Calcium,
pubmed-meshheading:7888300-Cell Differentiation,
pubmed-meshheading:7888300-Cell Division,
pubmed-meshheading:7888300-Cell Line,
pubmed-meshheading:7888300-Cell Survival,
pubmed-meshheading:7888300-Cytosol,
pubmed-meshheading:7888300-Humans,
pubmed-meshheading:7888300-Ion Transport,
pubmed-meshheading:7888300-Lovastatin,
pubmed-meshheading:7888300-Tretinoin,
pubmed-meshheading:7888300-ras Proteins
|
pubmed:year |
1994
|
pubmed:articleTitle |
Lovastatin inhibits receptor-stimulated Ca(2+)-influx in retinoic acid differentiated U937 and HL-60 cells.
|
pubmed:affiliation |
Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Universität München, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|